Vivus

Arena Pharma: Using Options to Trade on FDA's Decision for Key Obesity Drug
Seeking Alpha
Fri, 08/27/10 - 11:10 am
Arena Pharmaceuticals
obesity
FDA
Vivus
Orexigen
Contrave
Qnexa
When the Disease Matters Most in Drug Approval
Motley Fool
Wed, 08/11/10 - 11:08 am
drug development
JNJ
Vivus
Valeant Pharmaceuticals
GSK
Pfizer
Abbott Laboratories
Arena's Obesity Drug Likely to Pass FDA Panel With Flying Colors
Seeking Alpha
Mon, 08/9/10 - 09:46 am
Arena Pharmaceuticals
obesity
Vivus
Orexigen
Contrave
Qnexa
FDA
Vivus slides after analyst downgrades to 'Sell'
Yahoo/AP
Tue, 08/3/10 - 07:01 pm
Vivus
downgrades
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Orexigen Steps Up Pace in Obesity Drug Race
Seeking Alpha
Sun, 08/1/10 - 02:47 pm
Orexigen
Arena Pharmaceuticals
Vivus
Contrave
Qnexa
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Fri, 07/30/10 - 11:05 am
Orexigen
obesity
Contrave
Vivus
Arena Pharmaceuticals
Vivus's Obesity Drug Raises Familiar Questions
Seeking Alpha
Mon, 07/26/10 - 11:16 am
Vivus
obesity
Arena Pharmaceuticals
Contrave
Orexigen
Qnexa
The Value of an SPA for Avanir Pharmaceuticals
Seeking Alpha
Fri, 07/23/10 - 06:38 am
Vivus
SPA
Avanir
Biotech Stock Mailbag: Ziopharm
TheStreet.com
Thu, 07/22/10 - 09:29 am
Ziopharm
MELA Sciences
Vivus
Safety Concerns May Sink Both Vivus and Its Obesity Drug Qnexa
BNET Pharma
Wed, 07/21/10 - 03:55 pm
obesity
Vivus
Qnexa
FDA
Arena Pharmaceuticals
Contrave
Orexigen
Weekly Pharma Roundup: GSK Settles, Vivus Disappoints, Ely Lilly Axes
Seeking Alpha
Mon, 07/19/10 - 09:13 am
GSK
Vivus
Eli Lilly
Biogen Idec
Novartis
Sanofi
Vernalis
Lessons Learned About the Outlook for New Obesity Drug Approval
Motley Fool
Sun, 07/18/10 - 07:43 am
obesity
Arena Pharmaceuticals
Vivus
Qnexa
Contrave
Orexigen
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Fri, 07/16/10 - 10:05 am
Vivus
Arena Pharmaceuticals
FDA
Orexigen
Contrave
Qnexa
Vivus: What Happens Next?
TheStreet.com
Fri, 07/16/10 - 08:21 am
Vivus
Qnexa
obesity
Contrave
Arena Pharmaceuticals
Orexigen
FDA
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
WSJ Online
Thu, 07/15/10 - 06:04 pm
FDA
obesity
Vivus
Qnexa
advisory panels
Orexigen
Arena Pharmaceuticals
Contrave
Arena rallies on FDA optimism; Vivus shares halted
Marketwatch
Thu, 07/15/10 - 11:17 am
FDA
advisory panels
Qnexa
Arena Pharmaceuticals
Vivus
Shares of obesity drug developers rise following study on Arena Pharmaceuticals' lorcaserin
Yahoo/AP
Thu, 07/15/10 - 10:19 am
obesity
Arena Pharmaceuticals
Qnexa
Contrave
Orexigen
Vivus
Live Blog--Vivus' FDA Advisory Panel
TheStreet.com
Thu, 07/15/10 - 09:10 am
Vivus
Orexigen
obesity
FDA
Arena Pharmaceuticals
advisory panels
Qnexa
Vivus's Obesity Drug Awaiting FDA Review: Expecting Positive Ruling
Seeking Alpha
Wed, 07/14/10 - 10:35 am
obesity
Qnexa
FDA
Vivus
Contrave
Orexigen
Arena Pharmaceuticals
Vivus's Implied Volatility Gets Extreme
Seeking Alpha
Tue, 07/13/10 - 09:16 pm
Vivus
Qnexa
obesity

Pages